Gan & Lee Pharmaceuticals.
Clinical trials sponsored by Gan & Lee Pharmaceuticals., explained in plain language.
-
New hope drug enters first human tests for Tough-to-Treat prostate cancer
Disease control Not yet recruitingThis is the first study in people to test a new drug called GLR2037 for men with advanced prostate cancer that has spread. The main goal is to find a safe dose and understand the drug's side effects in 65 participants. Researchers will also take initial measurements to see if the…
Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New diabetes shot aims to tame stubborn blood sugar
Disease control Not yet recruitingThis study is testing an experimental injection called GZR101-80 for adults with type 2 diabetes whose blood sugar is still too high despite taking diabetes pills or insulin. Researchers want to see if this new treatment can lower blood sugar levels more effectively over 16 weeks…
Phase: PHASE2 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
First test of a potential cheaper copy of a blockbuster drug
Knowledge-focused Not yet recruitingThis study aims to see if a new, potentially lower-cost version of the drug dupilumab (Dupixent®) is similar to the original. It will involve 198 healthy Chinese adult men who will receive a single injection and be closely monitored for safety and how the drug moves through their…
Phase: PHASE1 • Sponsor: Gan & Lee Pharmaceuticals. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC